• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

47.99 -0.45 (-0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
36 37 Next >
News headline image
3 Biotech Stocks to Buy and Hold for the Next 10 Years ↗
February 26, 2024
There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold ↗
February 26, 2024
Buy this stock if you're daring, but avoid it for now if you aren't. 
Via The Motley Fool
News headline image
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points ↗
February 24, 2024
Watch these five stocks, but the market is slightly extended. 
Via Investor's Business Daily
Topics Stocks
News headline image
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗
February 23, 2024
 
Via Benzinga
News headline image
Smart Money Is Betting Big In CRSP Options ↗
February 22, 2024
 
Via Benzinga
News headline image
Check Out What Whales Are Doing With CRSP ↗
February 14, 2024
 
Via Benzinga
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today ↗
February 09, 2024
 
Via Benzinga
News headline image
Stock Market Rallies To Record High On Nvidia: Weekly Review ↗
February 23, 2024
The stock market rally pulled back to start the week, but roared higher as booming Nvidia earnings and guidance fueled big AI-led gains. The S&P 500 and Dow Jones hit... Read More 
Via Investor's Business Daily
Topics Stocks
News headline image
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗
February 22, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Crispr Reports Its First Profit In 10 Quarters, And Shares Fly Out Of A Buy Zone ↗
February 21, 2024
The company recently gained approval in the U.S. and abroad for its first gene-editing drug. 
Via Investor's Business Daily
News headline image
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought ↗
February 20, 2024
These exciting players could deliver explosive growth over time. 
Via The Motley Fool
News headline image
Got $100? 2 Top Cathie Wood Stocks to Buy and Hold. ↗
February 04, 2024
These stocks are steals right now. 
Via The Motley Fool
News headline image
If You Invested $10,000 in CRISPR Therapeutics in 2019, This Is How Much You Would Have Today ↗
February 19, 2024
It would have been a great move. 
Via The Motley Fool
News headline image
3 Stocks That Cathie Wood Is Loving Now: February 2024 ↗
February 16, 2024
Looking for high-growth opportunities? Here are three Cathie Wood stocks for long-term investors to consider now. 
Via InvestorPlace
News headline image
What's Going On With Crispr Therapeutics Stock? ↗
February 15, 2024
Crispr Therapeutics shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeutics with a Peer Perform rating. Crispr Therapeutics' shares have... 
Via Benzinga
News headline image
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday ↗
February 15, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. 
Via MarketBeat
News headline image
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
The outlook for growth has made biotech one of the hottest investments of late - and Wall Street sees big comeback gains ahead in these two biotechs. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+ ↗
February 13, 2024
CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
News headline image
3 Gene Editing Stocks With Unprecedented Surge Potential ↗
February 13, 2024
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. 
Via InvestorPlace
News headline image
Cathie Wood Has 37% of Her Ark Invest Portfolio Invested in These 7 Stocks ↗
February 12, 2024
The famous investor owns some huge winners -- and big losers, too. 
Via The Motley Fool
News headline image
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗
February 11, 2024
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector. 
Via InvestorPlace
News headline image
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List ↗
February 09, 2024
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in February 2024 ↗
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider. 
Via InvestorPlace
News headline image
2 Healthcare Stocks to Buy Hand Over Fist in February ↗
February 08, 2024
Both companies are proven innovators. 
Via The Motley Fool
News headline image
Cathie Wood Just Bought These 3 Biotech Stocks. Should You? ↗
February 07, 2024
They aren't all long shots, but they're all innovative. 
Via The Motley Fool
News headline image
2 Cathie Wood Stocks I Plan on Buying for My Kids' Portfolios ↗
February 05, 2024
These two Cathie Wood holdings are great long-term buys. 
Via The Motley Fool
News headline image
Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements ↗
February 01, 2024
Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio. 
Via InvestorPlace
News headline image
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock ↗
January 31, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is taking a "hard pass" on Surgery Partners, Inc. (NASDAQ: SGRY). "That industry has been up and down and up and down," he added. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap